5K4I | Transferase Transferase Inhibitor | date | May 20, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Erk2 In Complex With Compound 22 | ||||||||||||||
authors | J.Yin, W.Wang | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Mitogen-Activated Protein Kinase 1 Chain: A Fragment: Residues 9-360 Synonym: Mapk 1,Ert1,Extracellular Signal-Regulated Kinase Map Kinase Isoform P42,P42-Mapk,Mitogen-Activated Protein K Mapk 2; Ec: 2.7.11.24 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Mapk1, Erk2, Prkm1, Prkm2 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.76 Å | ||||||||||||
ligand | 6QB, EDO | enzyme | Transferase E.C.2.7.11.24 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-y l)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development., Blake JF, Burkard M, Chan J, Chen H, Chou KJ, Diaz D, Dudley DA, Gaudino JJ, Gould SE, Grina J, Hunsaker T, Liu L, Martinson M, Moreno D, Mueller L, Orr C, Pacheco P, Qin A, Rasor K, Ren L, Robarge K, Shahidi-Latham S, Stults J, Sullivan F, Wang W, Yin J, Zhou A, Belvin M, Merchant M, Moffat J, Schwarz JB, J Med Chem. 2016 Jun 23;59(12):5650-60. doi: 10.1021/acs.jmedchem.6b00389. Epub, 2016 Jun 7. PMID:27227380 |
Data retrieval |
View 5K4I in 3D |
Visual 3D analysis of 5K4I |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5K4I |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |